These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 21165580

  • 1. Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells.
    Jiao JW, Wen F.
    Oncol Rep; 2011 Mar; 25(3):781-8. PubMed ID: 21165580
    [Abstract] [Full Text] [Related]

  • 2. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.
    Lu F, Hou YQ, Song Y, Yuan ZJ.
    Anat Rec (Hoboken); 2013 Jan; 296(1):56-63. PubMed ID: 23125179
    [Abstract] [Full Text] [Related]

  • 3. p38 Mitogen-activated protein kinase signaling, ERCC1 expression, and viability of lung cancer cells from never or light smoker patients.
    Planchard D, Camara-Clayette V, Dorvault N, Soria JC, Fouret P.
    Cancer; 2012 Oct 15; 118(20):5015-25. PubMed ID: 22415779
    [Abstract] [Full Text] [Related]

  • 4. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
    Wang W, Ke S, Chen G, Gao Q, Wu S, Wang S, Zhou J, Yang X, Lu Y, Ma D.
    Oncol Rep; 2004 Dec 15; 12(6):1365-70. PubMed ID: 15547764
    [Abstract] [Full Text] [Related]

  • 5. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
    Liu HZ, Yu C, Yang Z, He JL, Chen WJ, Yin J, Li WM, Liu HT, Wang YX.
    Mol Med Rep; 2011 Dec 15; 4(5):985-92. PubMed ID: 21687949
    [Abstract] [Full Text] [Related]

  • 6. [Relationship between nucleotide excision repair gene ERCC1 and resistance to cisplatin in ovarian cancer].
    Liu GY, Qu QX, Mi RR, Qi J.
    Zhonghua Zhong Liu Za Zhi; 2008 Mar 15; 30(3):184-7. PubMed ID: 18756932
    [Abstract] [Full Text] [Related]

  • 7. Metformin-mediated downregulation of p38 mitogen-activated protein kinase-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel.
    Tseng SC, Huang YC, Chen HJ, Chiu HC, Huang YJ, Wo TY, Weng SH, Lin YW.
    Biochem Pharmacol; 2013 Feb 15; 85(4):583-94. PubMed ID: 23228696
    [Abstract] [Full Text] [Related]

  • 8. The impacts of ERCC1 gene exon VIII alternative splicing on cisplatin-resistance in ovarian cancer cells.
    Sun Y, Li T, Ma K, Tian Z, Zhu Y, Chen F, Hu G.
    Cancer Invest; 2009 Nov 15; 27(9):891-7. PubMed ID: 19832035
    [Abstract] [Full Text] [Related]

  • 9. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.
    Watson JL, Greenshields A, Hill R, Hilchie A, Lee PW, Giacomantonio CA, Hoskin DW.
    Mol Carcinog; 2010 Jan 15; 49(1):13-24. PubMed ID: 19676105
    [Abstract] [Full Text] [Related]

  • 10. Tanshinone IIA inhibits BT-20 human breast cancer cell proliferation through increasing caspase 12, GADD153 and phospho-p38 protein expression.
    Yan MY, Chien SY, Kuo SJ, Chen DR, Su CC.
    Int J Mol Med; 2012 May 15; 29(5):855-63. PubMed ID: 22322382
    [Abstract] [Full Text] [Related]

  • 11. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].
    Yang XK, Xing H, Zheng F, Gao QL, Wang W, Lu YP, Ma D.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Mar 15; 38(3):158-61. PubMed ID: 12816691
    [Abstract] [Full Text] [Related]

  • 12. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.
    Du P, Zhang X, Liu H, Chen L.
    DNA Cell Biol; 2015 Jul 15; 34(7):497-502. PubMed ID: 25941922
    [Abstract] [Full Text] [Related]

  • 13. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
    Ma JJ, Chen BL, Xin XY.
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct 15; 146(2):222-6. PubMed ID: 19758744
    [Abstract] [Full Text] [Related]

  • 14. Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance.
    Li W, Melton DW.
    Oncogene; 2012 May 10; 31(19):2412-22. PubMed ID: 21996734
    [Abstract] [Full Text] [Related]

  • 15. NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas.
    Engels K, Knauer SK, Loibl S, Fetz V, Harter P, Schweitzer A, Fisseler-Eckhoff A, Kommoss F, Hanker L, Nekljudova V, Hermanns I, Kleinert H, Mann W, du Bois A, Stauber RH.
    Cancer Res; 2008 Jul 01; 68(13):5159-66. PubMed ID: 18593915
    [Abstract] [Full Text] [Related]

  • 16. Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2.
    Ko JC, Su YJ, Lin ST, Jhan JY, Ciou SC, Cheng CM, Chiu YF, Kuo YH, Tsai MS, Lin YW.
    Lung Cancer; 2010 Aug 01; 69(2):155-64. PubMed ID: 19962780
    [Abstract] [Full Text] [Related]

  • 17. Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells.
    Yang X, Xing H, Gao Q, Chen G, Lu Y, Wang S, Ma D.
    Gynecol Oncol; 2005 May 01; 97(2):413-21. PubMed ID: 15863139
    [Abstract] [Full Text] [Related]

  • 18. [Relationship between expression of apoptosis-associated proteins and caspase-3 activity in cisplatin-resistant human ovarian cancer cell line].
    Yang XK, Zheng F, Chen JH, Gao QL, Lu YP, Wang SX, Wang CY, Ma D.
    Ai Zheng; 2002 Dec 01; 21(12):1288-91. PubMed ID: 12520732
    [Abstract] [Full Text] [Related]

  • 19. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
    Wang Y, Li LZ, Ye L, Niu XL, Liu X, Zhu YQ, Sun WJ, Liang YJ.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep 01; 45(9):691-8. PubMed ID: 21092551
    [Abstract] [Full Text] [Related]

  • 20. Synergistic effect of curcumin and cisplatin via down-regulation of thymidine phosphorylase and excision repair cross-complementary 1 (ERCC1).
    Tsai MS, Weng SH, Kuo YH, Chiu YF, Lin YW.
    Mol Pharmacol; 2011 Jul 01; 80(1):136-46. PubMed ID: 21493726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.